| Application no. and date | 14702642.1 (espacenet) (Federated) (European Patent Register), 20140122 | | Patent/reg. no. and date | DK/EP 2948461, 20191225 | | Publication date | 20151202 | | Priority no. and date | US 201361755537 P, 20130123, US 201361859910 P, 20130730 | | EP pub. no. and date |
EP 2948461 20151202 | | Effective date | | | Applicant/owner | Entasis Therapeutics Limited, 3rd Floor
1 Ashley Road
Altrincham
Cheshire WA14 2DT, GB | | Applicant ref. no. | MCCQ/P58877EP | | Inventor | ZHOU, Fei, AstraZeneca R & D Boston
35 Gatehouse Drive
Waltham, Massachusetts 02451, US,
BASARAB, Gregory, Steven, AstraZeneca R&D Boston
35 Gatehouse Drive
Waltham, Massachusetts 02451, US,
GOWRAVARAM, Madhusudhan, Reddy, c/o Astrazeneca Intellectual Property
AstraZeneca R&D Boston
35 Gatehouse Drive
Waltham, Massachusetts 02451, US,
HAUCK, Sheila, Irene, c/o Astrazeneca Intellectual Property
AstraZeneca R&D Boston
35 Gatehouse Drive
Waltham, Massachusetts 02451, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/535 (2006.01) , A61P 31/04 (2006.01) , C07D 498/22 (2006.01) | | Title | Compounds and methods for treating bacterial infections | | Int. application no. | GB2014050164 | | Int. publication no. | WO2014114929 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
